New Omicron Vaccine to Be Ready By March
Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine. Watch our video for all the details.
Currently many people who have taken the 2 doses of COVID vaccine are getting infected with Omicron.
This is why Pfizer Inc and BioNTech have said that they have started a clinical trial to test a new vaccine specifically designed to offer protection against the Omicron variant. About 1400 people will be enrolled in the trial. All of them are from the USA. In these 1400 people, those who have gotten the 2 COVID vaccine doses, will be given the Omicron vaccine as a booster dose. Those who have not taken any vaccine will be given the Omicron vaccine in 3 doses after specific intervals.
Those who have taken the 3rd dose of the covid vaccine will be given the Omicron vaccine as the 4th dose. All these people will be closely monitored to see if their immune systems can become strong and protect the body from the Omicron virus. According to the companies, the Omicron vaccine should be ready in March and they have already started manufacturing the doses. Once the trial results emerged positive they will sell them to various countries.
Head of Indian Council of Medical Research’s Epidemiological Department has said “If we all continue to follow rules like wear mask, sanitise and practise social distancing, then Covid may become endemic by 11 March. An endemic is a type of disease that is regularly found in a particular place or among a particular group of people and is difficult to get rid of.”
